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Introduction. Single incision laparoscopic surgery (SILS) has gained increasing support over the last few years. The aim of this
narrative review is to analyse the published evidence on the use and potential benefits of SILS in hepatic and pancreatic resectional
surgery for benign andmalignant pathology.Methods. Pubmed and Embase databases were searched using the search terms “single
incision laparoscopic”, “single port laparoscopic”, “liver surgery”, and “pancreas surgery”. Results. Twenty relevant manuscripts for
liver and 9 for pancreatic SILS resections were identified. With regard to liver surgery, despite the lack of comparative studies with
other minimal invasive techniques, outcomes have been acceptable when certain limitations are taken into account. For pancreatic
resections, when compared to the conventional laparoscopic approach, SILS produced comparable results with regard to intra- and
postoperative parameters, including length of hospitalisation and complications. Similarly, the results were comparable to robotic
pancreatectomies, with the exception of the longer operative time reported with the robotic approach. Discussion. Despite the
limitations, the published evidence supports that SILS is safe and feasible for liver and pancreatic resections when performed by
experienced teams in the tertiary setting. However, no substantial benefit has been identified yet, especially compared to other
minimal invasive techniques.
1. Introduction
Single incision laparoscopic surgery (SILS), first described by
Inoue et al. [1] more than two decades ago for an appen-
dectomy procedure, has gained support for the benefit of
improved cosmesis compared to the multiport laparoscopic
approach, as well as the potential reduction in the risk of
port-related complications, such as bleeding and visceral
injury, less postoperative pain, shorter length of stay, and
quicker return to work [2–6]. This innovative approach has
been further applied to a broad range of operations, such
as cholecystectomy, gastrectomy, colectomy, and splenectomy
[7–11]. With regard to liver and pancreas surgery, data on the
use of SILS are still limited to case reports and small series.
The purpose of this narrative review is to analyse the
published evidence on the use and potential benefits of SILS
in hepatic and pancreatic resectional surgery for benign and
malignant pathology.
2. Methods
A literature search of the Pubmed and Embase databases was
performed by two independent researchers (NAC and KD)
using the search terms “single incision laparoscopic”, “single
port laparoscopic”, “liver surgery”, and “pancreas surgery”.
The search was confined to English manuscripts. As this is a
narrative review, ethical approval was not required. Relevant
references cited in the literature were reviewed and included
where appropriate.
3. Results
Initial literature search identified 51 publications for liver and
21 for pancreatic surgery. Cases of liver cysts deroofing were
excluded from the analysis. Due to the limited amount of
data, case reports were included. After review of publications,
20 manuscripts for liver and 9 for pancreatic SILS resectional
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surgery were deemed relevant and included in the analysis
(Figure 1).
3.1. Liver Resectional Surgery. Over the last couple of decades,
significant progress has been made in the field of mini-
mally invasive liver surgery. It is now well established that
laparoscopic liver resections are feasible and safe and produce
comparable oncological outcomes to open resections, while
resulting in shorter hospital stay and blood loss [40–42].
SILS is the most recent development in the laparoscopic
approaches to liver surgery with increasing amount of data
presented in the literature. Nonetheless, no studies compar-
ing SILS with open or conventional multiport laparoscopic
or robotic liver resectional surgery are currently available in
the literature.
Various limitations have been described with the SILS
approach, mainly with regard to the size and location of the
lesions and the body mass index (BMI) of the patient. Easily
accessible, superficial lesions in segments II, III, IV, V, and
VIII [20, 28] are preferable, even though bigger or more
technically challenging resections for less favourably located
tumours have been described with increased experience in
the technique (Table 1). With regard to the size of the lesions,
most groups adopted a cut-off of <2.5–5 cm in diameter for
malignant and <10 cm for benign tumours [12, 14, 20–22, 27,
28, 31]. Resection of larger malignant lesions has also been
described [15, 20, 22]; however the potential extension of the
incision for extraction of large specimen defeats the purpose
of SILS [27]. Other contraindications include vascular or
extrahepatic involvement and morbid obesity [20, 27, 28].
Even though a history of upper abdominal surgery is a
relative contraindication for some groups [28], SILS liver
resections in patients with previous hepatectomies [22], as
well as a synchronous liver and colonic resection [22], have
been described.
A detailed description of the technique is beyond the
remit of this review. Briefly, the patient is positioned supine
in reverse Trendelenburg, with the legs apart to facilitate the
position of the primary surgeon [15, 21, 22, 26–28]. Patient
positioning in left lateral or semilateral positions has also
been described [15]. Transumbilical incision with a 3-trocar
technique has been used by most groups, while right upper
quadrant incision has also been described [15, 24]. The latter
may become useful in the setting of portal hypertension with
umbilical varices or lesions in distant segments. Standard
liver resection techniques were used with a combination
of ultrasonic and other energy devices, clips, and staplers.
Articulating instruments and scopes were also used in some
cases.
Median operative time was between 70 and 227 minutes
(Table 1). For larger resections (right or left hepatectomy)
reported operative times varied between 110 and 545minutes.
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A 0–26% conversion rate to multiport laparoscopic or open
procedure and acceptable blood loss for liver resectional
surgery were reported (Table 1). Median length of stay was
reported between 1 and 11 days (between 2 and 10 days for
large resections), with longer length of stay being attributed
to postoperative complications.
3.2. Pancreatic Resectional Surgery. As with liver surgery,
minimally invasive approaches have been gaining support in
the field of pancreatic surgery. Published evidence suggest
that laparoscopic pancreatic resections have comparable
oncological outcomes to open surgery and additional benefits
with regard to postoperative pain andmorbidity [43–45].The
SILS approach is less well established, with only a few cases
and small series reported in the literature. Indications for
SILS pancreatic resections included a variety of pathologies,
benign and malignant (Table 2). Due to the technical chal-
lenge, strict selection criteria are usually used. Smaller lesions
(<3.5 cm) are preferable, even though resections of larger
ones have been described. Ideally, patients should have a low
BMI, no history of previous abdominal surgery, and strong
preference for cosmesis [38]. All published cases have been
performed for favourably located lesions in the body and/or
tail of the pancreas and include distal pancreatectomies, with
or without splenic preservation. Exceptions are two local
excisions of lesions in infants, with one of them being a case
of enucleation of pancreatoblastoma from the head of the
pancreas [39].
Aswith every laparoscopic procedure, patient positioning
is of high importance. Supine [2, 32, 34, 36, 38, 39], right lat-
eral [35], and semilateral [33, 37] positions with [2, 32, 34, 38,
39] or without legs apart have been described, while reverse
Trendelenburg after establishing the pneumoperitoneumwas
used by all groups.The surgical technique described is similar
among the reports with minor modifications. Umbilical
incision was used mainly, with one group describing left
pararectal incision for very distal lesions [33]. Most com-
monly a 3-trocar technique [32, 34, 35, 37–39] was used,
while the use of scope and instruments varied (angulating
and straight both reported). Subsequent dissection followed
the standard laparoscopic steps with the use of an energy
device for the sealing of smaller vessels, while the main
splenic vessels were secured generally with the use of staplers
or clips. Staplers were used for the pancreatic parenchymal
transection. Gastric traction sutures have been described by
some groups to facilitate better exposure of the pancreas
[2, 32, 34, 35, 37]. Median operative time has been reported
between 145 and 330 minutes with a 0–19% conversion rate
and acceptable levels of blood loss (Table 2). Median length
of stay varied between 2 and 7 days, while themost commonly
reported complication was postoperative pancreatic fistula
formation.
Despite the small number of cases, two single cen-
tre retrospective studies compared the results of the SILS
approach to those of conventional laparoscopic distal pan-
createctomy [33, 38]. Both reported no significant difference
in the patients’ characteristics between the two groups. More
specifically, there was no significant difference with regard to
patients’ age [33, 38], ASA class [33], gender [38], and weight
andBMI [33, 38]. Similarly, therewas no significant difference
in the size [33, 38] or type [38] of the lesions. Intraoperative
parameters, such as operative time [33, 38], blood loss [33,
38], and conversion rate to open procedure [38], were also
comparable, as well as postoperative parameters, such as pain
[38], length of stay [33, 38], and complications [33, 38].
A comparison between SILS and robotic distal pancrea-
tectomy and splenectomy has also been reported, based also
on a retrospective analysis of a single centre cohort, which
included cases performed for malignant disease [36]. With
the exception of the longer operative time reported with the
robotic approach (297 versus 254 minutes, 𝑝 = 0.03), no
significant differences were identified with regard to patients’
age, BMI, blood loss, conversion rate, and size of the tumours.
Of note, the group acknowledged the preference towards the
SILS approach in patients with normal or low BMI, as the
operating space in these patients may not be sufficient for the
effective use of the robotic arms. Postoperative complication
rate was also comparable between the two groups; nonethe-
less a case of mortality was reported in the robotic group.
4. Discussion
SILS is one of the latest evolutions in minimal invasive
surgery and has been increasingly utilised in abdominal
surgery. The evidence on its use in liver and pancreatic
resectional surgery is scarce and limited to published case
reports and small case series.
The main advantage of SILS is cosmesis, with the benefits
of minimal or no-scar access advocated by various groups
[14, 15, 27, 30, 34]. It also carries a lower risk for port site
related complications, such as visceral injury and bleeding, as
well as potentially less postoperative pain, reduced length of
stay, and quicker return to work [2–6]. In liver and pancreatic
resectional surgery, the benefits of SILS are still unclear. Due
to the lack of prospective and randomised comparative stud-
ies between SILS and other minimally invasive approaches,
such as the conventional multiport or robotic techniques, the
evidence is currently based on retrospective analyses of small
case series [33, 36, 38]. However, as SILS is a relatively new
approach and the international experience is still small, the
potential benefits might be more obvious in the future.
SILS is considered less invasive than standard multiport
laparoscopy but has significant technical difficulties and lim-
itations. The main one arises from difficult instrumentation
due to the lack of space and triangulation. Therefore, SILS
is mainly limited to low BMI patients with no history of
previous abdominal surgery. Articulated laparoscopic tele-
scopes and instruments have also been utilised in order
to overcome this problem, but with significant increase in
the cost of the operation [34]. In the context of major
resectional surgery, such as liver and pancreatic surgery, the
lack of space and triangulationmight compromise the dissec-
tion and potentially the resection margins, while important
manoeuvres, such as access to the hilum, Pringle’s, or other
emergency haemostatic manoeuvres, become very difficult
to apply [27]. The length of the instruments also poses a
potential problem for liver resections and also for small distal
pancreatic lesions. With SILS through an umbilical incision,
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sometimes instruments are not long enough to reach the
entire dissection surface. Some groups have described the
use of right or left upper quadrant ports to overcome this
problem [15, 24, 33] and even the design of customised longer
instruments [15]. Furthermore, the small number of ports
and space limit retraction capabilities. This is particularly
important in the setting of pancreatic resectional surgery,
where stomach traction sutures have been used by some
groups [2, 32, 34, 35, 37].
Many surgeons prefer to leave an abdominal drain in the
setting of liver and more commonly pancreatic resections.
Some groups reported the use of the umbilical port as a drain
exit site [2, 35], while the use of an additional 5mm port that
can subsequently be converted into the drain exit site has also
been reported [34]. Although a potential disadvantage of SILS
could be the increased risk for the development of incisional
herniae due to the longer incision for the insertion of the SILS
port system, thiswas not supported by the published evidence
(Tables 1 and 2).
With regard to its main potential benefit, improved
cosmesis, many reports suggest good to excellent results [13,
21, 26, 30, 34, 35, 38], with less scarring [38] and improved
cosmesis [15, 28] for both liver [13, 15, 21, 26, 28, 30] and
pancreatic resections [34, 35, 38]. Despite the fact that many
series reported high levels of patient satisfaction [13, 14, 21,
28], only one study measured this during the first postopera-
tive follow-up visit after SILS liver resection [21].When asked
to categorise their aesthetic satisfaction to poor, fair, good, or
very good, themajority of patients (𝑛 = 4) were very satisfied,
with one patient reporting good aesthetic result.
The vast majority of the experience with SILS in liver
surgery refers to smaller resections (nonanatomical, left lat-
eral sectionectomy and segmentectomies), with only 7 major
hepatectomies reported in the literature (Table 1). The high
level of technical difficulty limits, at least in the beginning
of the learning curve, the use of the SILS approach to
small, superficial, and easily accessible lesions. It is generally
accepted that, ideally, patients should have a low BMI and no
previous upper abdominal surgery, even though exceptions to
these have also been reported [22]. Even though liver resec-
tions in cirrhotics may pose a greater challenge, SILS has also
been described in this group of patients. Nonetheless, most
cases were limited to early Child’s A stage patients [12, 20, 28,
31], with only 3 cases reported in Child’s B [12, 31] and 1 case
in a Child’s C patient [31].The small number of reported SILS
liver resections in the literature precludes direct comparison
with laparoscopic surgery. Nonetheless, themedian operative
time of 70–227 minutes is not substantially different than
the time (99–331 minutes) reported for laparoscopic hepatec-
tomies [42]. Similarly, the estimated blood loss (<50–500mL
for SILS and 50–659mLs for laparoscopic [42]) is also com-
parable.The wide range of the 0–26% conversion rate reflects
the technical difficulties and long learning curve of the SILS
approach. With increasing experience this is expected to
approach the 4% conversion rate [42] of the laparoscopic
approach. No mortality has been reported after SILS hepate-
ctomy, while low complication rates and only 3 cases of liver
specific complications were reported (Table 1). These results
resemble the low mortality (0.3%) and morbidity (10.5%)
rates after laparoscopic liver resections [42]. Keeping inmind
the technical limitations of the SILS approach and despite the
lack of randomised control trials and prospective compara-
tive studies between SILS andmultiport laparoscopic surgery,
the published evidence generally supports the view that SILS
is safe and feasible for liver resections when performed by
experienced teams in the tertiary setting.
With regard to pancreatic surgery, only a limited number
of reports is available with regard to SILS distal pancreatec-
tomy with or without splenectomy, supporting its safety and
feasibility in the appropriate setting. The vast majority of the
cases were for benign disease with only 4 cases performed
for malignant lesions (3 pancreatic ductal adenocarcinomas
and 1 renal cancer metastasis to the pancreas) (Table 2). Any
conclusions on the benefits of SILS for pancreatic resectional
surgery should be made with caution, due to the lack of
randomised trials and prospective studies. Based on two
retrospective comparative case series, the results between
SILS and the conventional multiport laparoscopic approach
were comparable, without any substantial benefit in operative
time, blood loss, postoperative pain, length of stay, and
complication rate [33, 38].This highlights the question of any
real value of SILS in the context of pancreatic surgery. On
the contrary, supporters of this approach would argue that
its real benefits might become more obvious with increasing
experience and evolving technology, an argument which was
also valid in the early stages of development of laparoscopic
surgery. Furthermore, this issue becomes more complicated
after one retrospective case series reported comparable
results between SILS and robotic surgery of the pancreas
[36]. Once again, and in the absence of any strong evidence
(prospective randomised trials), the value of SILS becomes
questionable, especially as robotic pancreatic surgery has
already gainedwide acceptance in both benign andmalignant
resections. On the other hand, although no cost comparison
has been published between the two techniques, the robotic
approach is likely to have a higher capital cost.
In conclusion, published evidence has not shown any sub-
stantial benefit of SILS in the context of liver and pancreatic
resectional surgery, especially compared to other minimal
invasive techniques, such as multiport laparoscopic and
robotic surgery. Further studies in the form of prospective
and randomised controlled trials would be required to draw
safe conclusions about the value of this innovative approach.
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